Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Shenzhen Hepalink Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥399.43 Million ≈ $58.45 Million USD) by net assets (CN¥12.43 Billion ≈ $1.82 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)

Cash flow conversion efficiency of Shenzhen Hepalink Pharmaceutical Co Ltd from 2006 to 2025. This chart illustrates how Shenzhen Hepalink Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Shenzhen Hepalink Pharmaceutical Co Ltd stock price today for real-time trading data and today's change.

Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Shenzhen Hepalink Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shenzhen Hepalink Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenzhen Hepalink Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Shenzhen Hepalink Pharmaceutical Co Ltd (002399) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Solvac S.A. BR:SOLV	0.011x
Focus Technology Co Ltd SHE:002315	0.169x
RLJ Lodging Trust NYSE:RLJ	0.053x
Marqeta Inc NASDAQ:MQ	88.289x
Gansu Qilianshan Cement Group Co Ltd SHG:600720	0.016x
Farasis Energy Gan Zhou Co Ltd SHG:688567	0.036x
Lier Chemical Co Ltd SHE:002258	0.070x
Qingdao Huicheng Environmental Co Ltd SHE:300779	-0.010x

Annual Cash Flow Conversion Efficiency for Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shenzhen Hepalink Pharmaceutical Co Ltd from 2006 to 2025. Review 002399 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥12.08 Billion ≈ $1.77 Billion	CN¥1.71 Billion ≈ $250.66 Million	0.142x	-21.14%
2024-12-31	CN¥12.20 Billion ≈ $1.79 Billion	CN¥2.19 Billion ≈ $321.07 Million	0.180x	+441.34%
2023-12-31	CN¥11.99 Billion ≈ $1.75 Billion	CN¥398.22 Million ≈ $58.27 Million	0.033x	+154.47%
2022-12-31	CN¥12.41 Billion ≈ $1.82 Billion	CN¥-756.61 Million ≈ $-110.72 Million	-0.061x	-10499.68%
2021-12-31	CN¥11.52 Billion ≈ $1.69 Billion	CN¥-6.63 Million ≈ $-970.08K	-0.001x	-118.04%
2020-12-31	CN¥11.69 Billion ≈ $1.71 Billion	CN¥37.28 Million ≈ $5.46 Million	0.003x	+110.47%
2019-12-31	CN¥7.47 Billion ≈ $1.09 Billion	CN¥-227.60 Million ≈ $-33.31 Million	-0.030x	-128.48%
2018-12-31	CN¥6.24 Billion ≈ $913.80 Million	CN¥667.87 Million ≈ $97.73 Million	0.107x	+301.93%
2017-12-31	CN¥7.69 Billion ≈ $1.12 Billion	CN¥-407.12 Million ≈ $-59.57 Million	-0.053x	-223.79%
2016-12-31	CN¥8.09 Billion ≈ $1.18 Billion	CN¥346.07 Million ≈ $50.64 Million	0.043x	-57.90%
2015-12-31	CN¥8.79 Billion ≈ $1.29 Billion	CN¥893.71 Million ≈ $130.78 Million	0.102x	-7.00%
2014-12-31	CN¥8.35 Billion ≈ $1.22 Billion	CN¥912.80 Million ≈ $133.57 Million	0.109x	+109.44%
2013-12-31	CN¥8.07 Billion ≈ $1.18 Billion	CN¥420.97 Million ≈ $61.60 Million	0.052x	-11.41%
2012-12-31	CN¥8.05 Billion ≈ $1.18 Billion	CN¥473.89 Million ≈ $69.35 Million	0.059x	-66.83%
2011-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.41 Billion ≈ $205.63 Million	0.178x	+301.45%
2010-12-31	CN¥8.02 Billion ≈ $1.17 Billion	CN¥354.86 Million ≈ $51.93 Million	0.044x	-86.70%
2009-12-31	CN¥1.07 Billion ≈ $156.62 Million	CN¥355.81 Million ≈ $52.07 Million	0.332x	+155.03%
2008-12-31	CN¥307.83 Million ≈ $45.05 Million	CN¥40.13 Million ≈ $5.87 Million	0.130x	+37.85%
2007-12-31	CN¥146.44 Million ≈ $21.43 Million	CN¥13.85 Million ≈ $2.03 Million	0.095x	-87.95%
2006-12-31	CN¥91.33 Million ≈ $13.36 Million	CN¥71.66 Million ≈ $10.49 Million	0.785x	--

About Shenzhen Hepalink Pharmaceutical Co Ltd

SHE:002399 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.70 Billion

CN¥11.61 Billion CNY

Market Cap Rank

#6481 Global

#1231 in China

Share Price

CN¥9.31

Change (1 day)

-0.11%

52-Week Range

CN¥8.65 - CN¥12.56

All Time High

CN¥28.69